Pharmacoepidemiology in Japan: medical databases and research achievements.

J Pharm Health Care Sci

Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501 Japan.

Published: January 2016

Pharmacoepidemiology involves development of new models to predict safety in the development stages of pharmaceutical products, development of various guidelines and policy related to clinical trials, pharmacovigilance, establishment and implementation of risk management in postmarketing studies, and cost-effectiveness research in medical and social welfare sectors. Evaluations of safety, efficacy, and costs of pharmaceutical products must be developed in a different way. More recently, "big data" in medicine have become the driving force behind epidemiological studies that attempt to solve questions in the clinical setting. Furthermore, it is important to pursue cost-effectiveness considering the government's financial condition. Epidemiologic and economic research utilizing epidemiological data linked to cost data will provide scientific evidence for appropriate distribution of health resources.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729130PMC
http://dx.doi.org/10.1186/s40780-015-0016-5DOI Listing

Publication Analysis

Top Keywords

pharmaceutical products
8
pharmacoepidemiology japan
4
japan medical
4
medical databases
4
databases achievements
4
achievements pharmacoepidemiology
4
pharmacoepidemiology involves
4
involves development
4
development models
4
models predict
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!